Brief: Altamira Therapeutics Files For Resale Of Up To 2 Mln Shares By Selling Shareholder
10/04/2024 13:19
April 10 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS LTD: FILES FOR RESALE, FROM TIME TO
TIME,
OF UP TO 2 MILLION COMMON SHARES, BY SELLING SHAREHOLDER-SEC
FILING
Source text for Eikon: ID:n0001213900-24-031737
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering